Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. BioElectronics Corporation (BIEL) Message Board

Viant Medical appears to be a strategic enabler in

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 8723
(Total Views: 116)
Posted On: 10/11/2025 10:45:10 PM
Posted By: Bielionaire
Viant Medical appears to be a strategic enabler in the potential partnership between Electrome and BioElectronics Corporation (BIEL), with Sree Koneru serving as the connective tissue across all three entities. His dual role at Viant and BIEL strengthens the case for collaboration.

Viant’s Strategic Role in a BIEL–Electrome Partnership

1. Contract Manufacturing Backbone

Viant is a leading contract manufacturer specializing in wearable and implantable medical devices. With ISO-certified facilities and expertise in Class I–III devices, Viant could:

Manufacture next-gen versions of BIEL’s ActiPatch or RecoveryRx devices.

Support Electrome’s scale-up with clean-room assembly, smart sensor integration, and flexible form factors.

2. Leadership Synergy via Sree Koneru

Koneru is currently Director of Program Management at Viant and also sits on BIEL’s Board of Directors. This dual role enables:

Seamless communication between engineering, regulatory, and executive teams.

Strategic alignment on product modernization, cost optimization, and clinical validation.

3. Technology Modernization Pathway

Viant’s capabilities could help BIEL and Electrome co-develop:

A smartphone-powered, battery-free, ultra-flexible version of RecoveryRx.

Devices inspired by recent PRFE bandage research, but with FDA-cleared foundations.

4. Equity and Investment Potential

Some investor speculation suggests Viant could become an equity stakeholder in BIEL, especially as BIEL trades near historical lows. This opens doors for:

Strategic investment by Electrome or Viant.

Joint ventures targeting global reimbursement markets and retail expansion.

5. Clinical and Regulatory Acceleration

Viant’s infrastructure supports:

Faster FDA and CE submissions.

Efficient clinical trial execution, especially for neuromodulation technologies.

6. Partnership Scenario: Triangular Collaboration

BIEL

IP holder and product originator

FDA-cleared tech, clinical data

Electrome

Innovation and market expansion

New applications, branding, distribution

Viant

Manufacturing and engineering partner

Scale-up, modernization, regulatory support

Sree Koneru acts as the linchpin, connecting technical, regulatory, and strategic dots across all three.


(4)
(0)




BioElectronics Corporation (BIEL) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us